Literature DB >> 810282

Cytotoxic lymphocytes from normal donors. A functional marker of human non-T lymphocytes.

H F Pross, M Jondal.   

Abstract

A phenomenon we have termed spontaneous lymphocyte-mediated cytotoxicity (SLMC) by non-thymus-derived lymphocytes from normal donors has been described. The phenomenon can be demonstrated using human and xenogeneic (mouse) cell lines as the target cell in a microplate 51Cr release assay which is simple and reproducible. In this paper, SLMC against xenogeneic targets has been evaluated as a potential marker of lumphocytotoxic function with respect to: (a) the nature of the target cell; (b) the variability of the cytotoxic function of lymphocytes from different donors, and from the same donor tested on different days; (c) the nature of the effector cell. Using buoyant density centrifugation of iron plus magnetpurified lymphocytes forming rosettes with sheep red blood cells (SRBC) (T-cells) or SRBC-rabbit 19S anti-SRBC-mouse complement (complement receptor lymphocyte), it has been demonstrated that the cytotoxic activity lies in the non-T-lymphocyte fraction, and is probably caused by the complement receptor-bearing lymphocyte. The potential usefulness of this phenomenon as a functional marker of non-T-LYMPHOCYTE CYTOTOXIC Ability, and for the assessment of serological factors ehich may affect this cytotoxicity, has been discussed.

Entities:  

Mesh:

Year:  1975        PMID: 810282      PMCID: PMC1538269     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  19 in total

1.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

2.  Surface markers on human B and T lymphocytes. IV. Distribution of surface markers on resting and blast-transformed lymphocytes.

Authors:  M Jondal
Journal:  Scand J Immunol       Date:  1974       Impact factor: 3.487

3.  Formation of mouse or sheep red-blood-cell rosettes by lymphocytes from normal and leukaemic individuals.

Authors:  G Stathopoulos; E V Elliott
Journal:  Lancet       Date:  1974-04-06       Impact factor: 79.321

Review 4.  Human lymphocyte subpopulations: classification according to surface markers and-or functional characteristics.

Authors:  M Jondal; H Wigzell; F Aiuti
Journal:  Transplant Rev       Date:  1973

5.  Cytotoxicity of a factor isolated from human spleen.

Authors:  C B Lozzio; B B Lozzio
Journal:  J Natl Cancer Inst       Date:  1973-02       Impact factor: 13.506

6.  HL-A antigens and diseases. I. Multiple sclerosis.

Authors:  C Jersild; A Svejgaard; T Fog; T Ammitzboll
Journal:  Tissue Antigens       Date:  1973

7.  HL-A antigens and multiple sclerosis.

Authors:  J Bertrams; E Kuwert; U Liedtke
Journal:  Tissue Antigens       Date:  1972

8.  Relations of HL-A and Rh systems to immune reactivity. Joint report of the results of 'HL-A and immune response' workshop, Budapest 1972.

Authors: 
Journal:  Vox Sang       Date:  1974       Impact factor: 2.144

9.  A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization.

Authors:  C Bianco; R Patrick; V Nussenzweig
Journal:  J Exp Med       Date:  1970-10-01       Impact factor: 14.307

10.  Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes.

Authors:  M Jondal; G Klein
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

View more
  47 in total

1.  Impaired T cell function and decreased natural killer activity in patients with liver cirrhosis and their significance in the development of hepatocellular carcinoma.

Authors:  T Morizane; T Watanabe; K Tsuchimoto; M Tsuchiya
Journal:  Gastroenterol Jpn       Date:  1980

2.  IL15 Infusion of Cancer Patients Expands the Subpopulation of Cytotoxic CD56bright NK Cells and Increases NK-Cell Cytokine Release Capabilities.

Authors:  Sigrid Dubois; Kevin C Conlon; Jürgen R Müller; Jennifer Hsu-Albert; Nancy Beltran; Bonita R Bryant; Thomas A Waldmann
Journal:  Cancer Immunol Res       Date:  2017-08-25       Impact factor: 11.151

Review 3.  The human NK cell--a short over-view and an hypothesis on NK recognition.

Authors:  M Jondal
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

4.  Natural cytotoxic reactivity of human lymphocyte subpopulations.

Authors:  M R Potter; M Moore
Journal:  Immunology       Date:  1979-05       Impact factor: 7.397

5.  The host environment is responsible for aging-related functional NK cell deficiency.

Authors:  Bo-Chin Chiu; Brian E Martin; Valerie R Stolberg; Stephen W Chensue
Journal:  J Immunol       Date:  2013-09-20       Impact factor: 5.422

6.  Spontaneous and antibody-dependent cell-mediated cytotoxicity by human T cell subpopulations.

Authors:  S Gupta; G Fernandes; M Nair; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

7.  Human spontaneous lymphocyte-mediated cytotoxicity (SLMC) against malignant and normal tissue-derived target cell lines tested in autologous and allogeneic combinations by the microcytotoxicity assay.

Authors:  M Vilien; M Troye-Blomberg; P Perlmann; H Wolf; F Rasmussen
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

8.  Spontaneous and antibody-dependent cellular cytotoxicity by lymphocyte subpopulations in peripheral blood and spleen from adult untreated patients with Hodgkin's disease.

Authors:  S Gupta; G Fernandes
Journal:  Clin Exp Immunol       Date:  1981-07       Impact factor: 4.330

9.  Proliferation of T gamma-lymphocytes in two patients: clinical features and functional properties of the proliferating cells.

Authors:  G Schlimok; E Thiel; E P Rieber; D Huhn; H Feucht; D Renner; G Riethmüller
Journal:  Klin Wochenschr       Date:  1982-02-01

10.  Presence of natural killer cells in Peyer's patches of the mouse.

Authors:  M J Kamiński; M Jakóbisiak
Journal:  Experientia       Date:  1980-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.